Who has invested in Aimmune Therapeutics?

Nestlé are named among the investors backing Aimmune Therapeutics.

Aimmune Therapeutics Funding: $2.6B Raised

Aimmune Therapeutics funding overview

Aimmune Therapeutics is based in Brisbane. Aimmune Therapeutics has raised $2.6B in total disclosed funding. That places its disclosed total in over $1B. The round record for Aimmune Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Nestlé.

Aimmune Therapeutics at a glance

Total raised: $2.6B
Latest round date: August 2020
Headquarters: Brisbane
Notable investors: Nestlé

Frequently asked about Aimmune Therapeutics funding

How much has Aimmune Therapeutics raised?: Aimmune Therapeutics has raised $2.6B in total disclosed funding across the rounds on record.
Who has invested in Aimmune Therapeutics?: Nestlé are named among the investors backing Aimmune Therapeutics.
What was the latest Aimmune Therapeutics funding round?: No round stage has been disclosed for Aimmune Therapeutics.
Where is Aimmune Therapeutics based?: Aimmune Therapeutics is based in Brisbane.
When did Aimmune Therapeutics last raise?: The last disclosed Aimmune Therapeutics round closed in August 2020.

We update the Aimmune Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Brisbane and their backers are listed below.

Aimmune Therapeutics Funding: $2.6B Raised

Aimmune Therapeutics funding overview

Aimmune Therapeutics at a glance

Frequently asked about Aimmune Therapeutics funding

Companies related to Aimmune Therapeutics (19)

Browse related funding lists (2)